PReCePT was developed by the West of England AHSN in collaboration with University Hospitals Bristol NHS Foundation Trust, and involving both patients and staff. This evidence-based, cost-effective project has been designed to help reduce cerebral palsy in babies through increased antenatal administration of magnesium sulphate (MgSO4) to mothers during preterm labour, at cost of £1 per individual dose.
The intervention has been adopted by all five maternity units in the West of England, and projection modelling indicates that since the launch of the project in August 2014, phase one of PReCePT has prevented seven cases of cerebral palsy across the region, representing potential lifetime savings in the region of £5.1 million (as of February 2017).
PReCePT has been selected by the Health Foundation to be part of an ambitious £3.5 million 'Scaling Up' improvement programme, which will see the initiative rolled out to a further 10 trusts across the country. Find out more at weahsn.net/news/project-prevent-cerebral-palsy-premature-babies-wins-scaling-funding-health-foundation/
PReCePT has also been selected as one of the AHSN Network's programmes for national adoption and spread in 2018-20. Find out more at ahsnnetwork.com/about-academic-health-science-networks/national-programmes-priorities/precept/